nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.902	1	CbGbCtD
Pitavastatin—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00651	0.105	CcSEcCtD
Pitavastatin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0572	CcSEcCtD
Pitavastatin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0464	CcSEcCtD
Pitavastatin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0445	CcSEcCtD
Pitavastatin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0427	CcSEcCtD
Pitavastatin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0403	CcSEcCtD
Pitavastatin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00232	0.0372	CcSEcCtD
Pitavastatin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0023	0.037	CcSEcCtD
Pitavastatin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00195	0.0313	CcSEcCtD
Pitavastatin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0311	CcSEcCtD
Pitavastatin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00187	0.03	CcSEcCtD
Pitavastatin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0292	CcSEcCtD
Pitavastatin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0275	CcSEcCtD
Pitavastatin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0275	CcSEcCtD
Pitavastatin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0272	CcSEcCtD
Pitavastatin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0266	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0015	0.024	CcSEcCtD
Pitavastatin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.0239	CcSEcCtD
Pitavastatin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0232	CcSEcCtD
Pitavastatin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0228	CcSEcCtD
Pitavastatin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0226	CcSEcCtD
Pitavastatin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0218	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0216	CcSEcCtD
Pitavastatin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00131	0.021	CcSEcCtD
Pitavastatin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0209	CcSEcCtD
Pitavastatin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0194	CcSEcCtD
Pitavastatin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0189	CcSEcCtD
Pitavastatin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0187	CcSEcCtD
Pitavastatin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0181	CcSEcCtD
Pitavastatin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0175	CcSEcCtD
Pitavastatin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0166	CcSEcCtD
Pitavastatin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0166	CcSEcCtD
Pitavastatin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0165	CcSEcCtD
Pitavastatin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000977	0.0157	CcSEcCtD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000108	0.00302	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000108	0.00301	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—DAO—amyotrophic lateral sclerosis	0.000107	0.003	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000107	0.00299	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000106	0.00297	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000106	0.00297	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000104	0.00292	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000104	0.00291	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000103	0.00289	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000103	0.00287	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000103	0.00287	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000103	0.00287	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000103	0.00287	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000101	0.00282	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000101	0.00282	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	9.99e-05	0.00279	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.96e-05	0.00279	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	9.89e-05	0.00277	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.87e-05	0.00276	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.81e-05	0.00274	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.68e-05	0.00271	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	9.66e-05	0.0027	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.41e-05	0.00263	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	9.39e-05	0.00263	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GSR—amyotrophic lateral sclerosis	9.19e-05	0.00257	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—FIG4—amyotrophic lateral sclerosis	9.1e-05	0.00254	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.02e-05	0.00252	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.99e-05	0.00252	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.97e-05	0.00251	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	8.97e-05	0.00251	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.76e-05	0.00245	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	8.73e-05	0.00244	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.73e-05	0.00244	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	8.56e-05	0.00239	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.49e-05	0.00237	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.39e-05	0.00235	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.37e-05	0.00234	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.34e-05	0.00233	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—DAO—amyotrophic lateral sclerosis	8.23e-05	0.0023	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	8.21e-05	0.0023	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	8.17e-05	0.00228	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PLB1—amyotrophic lateral sclerosis	8.12e-05	0.00227	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	8.11e-05	0.00227	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.03e-05	0.00225	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.98e-05	0.00223	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.97e-05	0.00223	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.89e-05	0.00221	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.84e-05	0.00219	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.65e-05	0.00214	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.65e-05	0.00214	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	7.62e-05	0.00213	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	7.56e-05	0.00211	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.55e-05	0.00211	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSR—amyotrophic lateral sclerosis	7.49e-05	0.0021	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	7.44e-05	0.00208	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	7.43e-05	0.00208	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.38e-05	0.00206	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.34e-05	0.00205	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.22e-05	0.00202	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.22e-05	0.00202	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	7.22e-05	0.00202	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.13e-05	0.00199	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.08e-05	0.00198	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.08e-05	0.00198	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.07e-05	0.00198	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.99e-05	0.00196	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.89e-05	0.00193	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.83e-05	0.00191	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.82e-05	0.00191	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	6.79e-05	0.0019	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	6.79e-05	0.0019	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.78e-05	0.0019	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.78e-05	0.0019	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	6.62e-05	0.00185	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.62e-05	0.00185	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	6.57e-05	0.00184	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.5e-05	0.00182	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.5e-05	0.00182	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.48e-05	0.00181	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.43e-05	0.0018	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.42e-05	0.0018	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.28e-05	0.00176	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.28e-05	0.00176	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	6.26e-05	0.00175	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	6.24e-05	0.00174	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.19e-05	0.00173	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CHAT—amyotrophic lateral sclerosis	6.15e-05	0.00172	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.11e-05	0.00171	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	6.11e-05	0.00171	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.04e-05	0.00169	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.02e-05	0.00168	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	5.76e-05	0.00161	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.73e-05	0.0016	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	5.66e-05	0.00158	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.66e-05	0.00158	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.66e-05	0.00158	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	5.63e-05	0.00157	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.61e-05	0.00157	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.6e-05	0.00156	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	5.53e-05	0.00155	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.41e-05	0.00151	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.38e-05	0.0015	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	5.26e-05	0.00147	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	5.25e-05	0.00147	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.24e-05	0.00147	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	5.19e-05	0.00145	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	5.12e-05	0.00143	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	5.1e-05	0.00143	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	5.05e-05	0.00141	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	5.02e-05	0.0014	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	4.78e-05	0.00134	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	4.73e-05	0.00132	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.72e-05	0.00132	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.67e-05	0.00131	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.6e-05	0.00129	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.56e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	4.48e-05	0.00125	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	4.42e-05	0.00124	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.4e-05	0.00123	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	4.39e-05	0.00123	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	4.39e-05	0.00123	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.39e-05	0.00123	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	4.37e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	4.37e-05	0.00122	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.31e-05	0.00121	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	4.29e-05	0.0012	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	4.29e-05	0.0012	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	4.26e-05	0.00119	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.22e-05	0.00118	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.19e-05	0.00117	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.1e-05	0.00115	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	4.09e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.07e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.06e-05	0.00113	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	4.02e-05	0.00112	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	4e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.99e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.88e-05	0.00109	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.87e-05	0.00108	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.87e-05	0.00108	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	3.87e-05	0.00108	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.85e-05	0.00108	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.83e-05	0.00107	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.83e-05	0.00107	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.8e-05	0.00106	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	3.78e-05	0.00106	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.74e-05	0.00105	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.73e-05	0.00104	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.72e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	3.58e-05	0.001	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.58e-05	0.001	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.58e-05	0.001	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.52e-05	0.000985	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	3.51e-05	0.000983	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.5e-05	0.000979	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	3.49e-05	0.000977	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.45e-05	0.000966	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.39e-05	0.000949	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.39e-05	0.000949	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.33e-05	0.000933	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.31e-05	0.000925	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.27e-05	0.000915	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.26e-05	0.00091	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	3.18e-05	0.000889	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.18e-05	0.000888	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	3.16e-05	0.000884	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.07e-05	0.000858	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.06e-05	0.000856	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.04e-05	0.000851	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.04e-05	0.00085	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.03e-05	0.000846	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.95e-05	0.000826	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.94e-05	0.000822	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	2.92e-05	0.000815	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.9e-05	0.00081	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.87e-05	0.000803	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.86e-05	0.0008	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.77e-05	0.000774	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.7e-05	0.000754	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.59e-05	0.000723	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.54e-05	0.00071	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—APOE—amyotrophic lateral sclerosis	2.5e-05	0.000699	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.48e-05	0.000693	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	2.46e-05	0.000689	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.41e-05	0.000673	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	2.39e-05	0.00067	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.38e-05	0.000666	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.33e-05	0.000653	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.29e-05	0.000641	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.22e-05	0.000621	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	0.000618	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.21e-05	0.000618	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	2.21e-05	0.000618	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	0.000589	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.1e-05	0.000588	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.1e-05	0.000587	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	2.04e-05	0.00057	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	0.000566	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	0.000563	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.99e-05	0.000555	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.96e-05	0.000548	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.94e-05	0.000541	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	1.92e-05	0.000537	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.9e-05	0.000533	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.87e-05	0.000524	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.82e-05	0.00051	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.81e-05	0.000507	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.81e-05	0.000506	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	1.73e-05	0.000485	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.71e-05	0.000479	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.71e-05	0.000477	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000466	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.66e-05	0.000463	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000461	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.59e-05	0.000445	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000442	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000439	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.5e-05	0.00042	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.000415	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000406	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.42e-05	0.000396	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.4e-05	0.000391	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000379	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.32e-05	0.000368	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.29e-05	0.000361	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000334	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	0.000332	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.14e-05	0.000319	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.13e-05	0.000317	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.81e-06	0.000275	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.81e-06	0.000274	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.75e-06	0.000273	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.28e-06	0.00026	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.01e-06	0.000252	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.96e-06	0.000251	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.84e-06	0.000247	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.54e-06	0.000239	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.19e-06	0.000229	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.98e-06	0.000223	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.85e-06	0.00022	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	7.42e-06	0.000207	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	7.41e-06	0.000207	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	7.37e-06	0.000206	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.33e-06	0.000205	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.46e-06	0.000181	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	6.03e-06	0.000169	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.08e-06	0.000142	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.05e-06	0.000141	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.43e-06	0.000124	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.14e-06	0.000116	CbGpPWpGaD
